Hilltop Bio specializes in the development of advanced regenerative therapies for animals, focusing on joint health, soft tissue repair, wound care, and ophthalmology. Their products leverage the body's own immune system to facilitate healing, providing clinical relief comparable to traditional pharmaceuticals without the use of steroids or NSAIDs. The company emphasizes the use of 100% natural materials, specifically humanely sourced birth tissues that contain cell-signaling molecules known to reduce inflammation and promote healing. Rigorous testing throughout the manufacturing process ensures that their biologic materials meet safety standards, reinforcing their commitment to quality and efficacy.

The product lineup includes various injectable therapies for both equine and canine patients, such as Strydaflex and Regenaflex formulations, designed for joint and soft tissue health. Additionally, Hilltop Bio offers wound care solutions like Regenaflex-M, a sterile bioscaffold membrane, and Regenaflex-Gel for topical applications. Their ophthalmic products, including PureOptic and specialized ocular discs, address eye health issues. The company is also actively engaged in research and development, exploring new therapies for respiratory health and conducting clinical trials for canine osteoarthritis, showcasing their dedication to innovation in veterinary medicine.

United States

TARGETED THERAPIES FOR EVERYDAY USE:  Hilltop Bio products are room-temperature stable, practical, and ready-to-go purified therapies containing specific levels of selected regenerative components like extracellular vesicles, exosomes, growth factors, cytokines and microRNA that studies have shown to be effective at minimizing inflammation and promoting  healing.

Hilltop Bio

Company Details